Tag: SARS-CoV-2
No increased risk of (severe) COVID-19 among IBD patients
COVID-19 in patients with rheumatic disease: most report mild disease
Poor disease control: a risk factor for severe COVID-19
No heightened outcome risk for rheumatic patients with COVID-19
Insufficient antimalarial supply for rheumatic disease treatment in the early COVID-19 pandemic
Biologic psoriasis treatment and COVID-19 risk: Contradictory results
Much to be learned about COVID-19 and the skin
COVID-19: Continuing versus suspending ACE inhibitors and ARBs
Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan
The Yale COVID-19 Cardiovascular Registry
